Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds - Concepedia

Concepedia

Publication | Closed Access

Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds

71

Citations

18

References

2013

Year

Luis Villar, Doris Maribel Rivera-Medina, José Luis Arredondo-Garcı́a, Mark Boaz, Linda Starr-Spires, Manoj Kumar Thakur, Betzana Zambrano, María Consuelo Miranda, Enrique Rivas, Gustavo H. Dayan

The Pediatric Infectious Disease Journal

Abstract

CYD-TDV had a favorable safety profile and elicited antibody responses against all 4 dengue virus serotypes in 9-16 year olds in Latin America. These findings support the continued development of CYD-TDV.

References

	Year	Citations

Page 1